AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE572.00-4.5 (-0.78 %)
PREV CLOSE ( ) 576.50
OPEN PRICE ( ) 577.90
BID PRICE (QTY) 571.75 (333)
OFFER PRICE (QTY) 572.00 (50)
VOLUME 67122
TODAY'S LOW / HIGH ( )570.00 580.00
52 WK LOW / HIGH ( )527.05 808.95
NSE572.65-3.65 (-0.63 %)
PREV CLOSE( ) 576.30
OPEN PRICE ( ) 577.75
BID PRICE (QTY) 572.45 (541)
OFFER PRICE (QTY) 572.65 (131)
VOLUME 660424
TODAY'S LOW / HIGH( ) 568.90 580.80
52 WK LOW / HIGH ( )527 809.45
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
16Jul Aurobindo Pharma, Bank of Baroda and K
Aurobindo Pharma has entered into a definite agreement with global gener..
16Jul Aurobindo Pharma’s arm enters into agr
Aurobindo Pharma’s wholly owned step-down subsidiary -- Agile Pharma BV..
16Jul Aurobindo Pharma gains with arm enteri
Aurobindo Pharma is currently trading at Rs. 607.45, up by 4.55points or..
11Jul Goa Carbon, Andhra Bank and PNB to see
Goa Carbon has reported production of 11,951 million tonnes (MT) of Calc..
11Jul Aurobindo Pharma receives USFDA approv
Aurobindo Pharma has received final approval from the US Food & Drug..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit3082.918127.7
Gross Profit 3752.8 23429.4
Operating Profit 4842.427506.6
Net Sales 23547.2103031.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7269.95 (1.26%)
M.Cap (Rs. in Cr)15371.21
Astrazeneca Pharma I (BSE)
 1467.60 (3.08%)
M.Cap (Rs. in Cr)3661.38
Zim Laboratories (BSE)
 367.00 (4.86%)
M.Cap (Rs. in Cr)295.79
Hester Biosciences (BSE)
 1176.05 (1.12%)
M.Cap (Rs. in Cr)1000.45
Merck (BSE)
 2254.45 (0.44%)
M.Cap (Rs. in Cr)3679.25
Shareholding Pattern
PROMOTERS 51.87%
MUTUAL FUNDS/UTI 15.23%
NON-INSTITUTION 14.53%
FI/BANKS/INSURANCE 0.59%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.